Defining the Functional Sensitivity for the Siemens Atellica Calcitonin Assay: Insight From a Single-Center Study.

Autor: Li J; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio. Electronic address: Jieli.li@osumc.edu., Patton A; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio., Lee JKY; Department of Clinical Laboratory, University Hospital, The Ohio State University, Columbus, Ohio., Scheidegger M; Department of Clinical Laboratory, University Hospital, The Ohio State University, Columbus, Ohio., Azaryan I; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio., Sipos JA; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio., Nabhan F; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio., Jones J; Department of Pathology, Wexner Medical Center, The Ohio State University, Columbus, Ohio., Algeciras-Schimnich A; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Ringel MD; Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio; Department of Molecular Medicine and Therapeutics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio. Electronic address: matthew.ringel@osumc.edu.

Publikováno v: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Nov; Vol. 30 (11), pp. 1044-1050. Date of Electronic Publication: 2024 Aug 26.

Beyond malignancy risk stratification: FNAC report anticipates thyroid cancer staging. Insights from recent studies.

Autor: Rotondi M; Department of Internal Medicine and Therapeutics, University of Pavia, 27100, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, 27100, Pavia, Italy., Endo M; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA 98195, USA., Teliti M; Department of Internal Medicine and Therapeutics, University of Pavia, 27100, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, 27100, Pavia, Italy., Crescenzi A; Department of Radiological, Oncological, and Pathological Sciences, Sapienza University of Rome, Rome, Italy., Azaryan I; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Croce L; Department of Internal Medicine and Therapeutics, University of Pavia, 27100, Italy.; Istituti Clinici Scientifici Maugeri IRCCS, Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, 27100, Pavia, Italy., Elisei R; Department of Clinical and Experimental Medicine, Unit of Endocrinology, Pisa University Hospital, Pisa, Italy., Fugazzola L; Department of Endocrine and Metabolic Diseases, Endocrine Oncology Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Cibas ES; Department of Pathology, Brigham and Women's Hospital, Boston, MA; Department of Pathology, Harvard Medical School, Boston, MA., Trimboli P; Endocrinology and Diabetology, Ente Ospedaliero Cantonale (EOC), Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università Della Svizzera Italiana (USI), Lugano, Switzerland., Sipos JA; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.

Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.

Autor: Endo M; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA.; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA 98195, USA., Peng J; Division of Human Genetics, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Nabhan FA; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Brock P; Center for Biostatistics and Bioinformatics, The Ohio State University, Columbus, OH 43210, USA., Azaryan I; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Long C; Department of Internal Medicine, New York University Langone Health, New York, NY 10016, USA., Ryan LE; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Ringel MD; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Sipos JA; Division of Endocrinology, Diabetes, and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA.

Publikováno v: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2024 Aug 13; Vol. 109 (9), pp. 2317-2324.

Ultrasound Features and Performance of Afirma Gene Sequencing Classifier in Cytologically Indeterminate Thyroid Nodules.

Autor: Azaryan I; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Endo M; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA.; Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, WA 98105, USA., Sipos JA; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA., Ma J; Center of Biostatistics and Bioinformatics, The Ohio State University, Columbus, OH 43210, USA., Peng J; Center of Biostatistics and Bioinformatics, The Ohio State University, Columbus, OH 43210, USA., Nabhan F; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University and Arthur G. James Cancer Center, Columbus, OH 43210, USA.

Publikováno v: Journal of the Endocrine Society [J Endocr Soc] 2024 Jan 31; Vol. 8 (3), pp. bvae010. Date of Electronic Publication: 2024 Jan 31 (Print Publication: 2024).

Coronary Artery and Peripheral Vascular Disease in a Patient with Poorly Differentiated Thyroid Cancer Treated with the Tyrosine Kinase Inhibitor Lenvatinib.

Autor: Sukrithan V; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Kim L; Department of Internal Medicine, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Sipos JA; Department of Internal Medicine, Division of Endocrinology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Goyal A; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Zhou Y; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Addison D; Department of Internal Medicine, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Shah M; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Konda B; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Vallakati A; Department of Internal Medicine, Division of Cardiology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Publikováno v: Case reports in endocrinology [Case Rep Endocrinol] 2023 Oct 31; Vol. 2023, pp. 8841696. Date of Electronic Publication: 2023 Oct 31 (Print Publication: 2023).